Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lee-Yuh Pai
Observed names:
L. Pai,
L.Y. Pai,
Lee-yuh Pai
Institution:
Merck & Co., Inc., Rahway, NJ, USA (United States)
Observed institutions:
Merck & Co., Inc., Rahway, NJ, USA (United States),
Karo Pharma (Sweden)
OpenAlex ID:
A5111694973
Estrogen Receptor Ligands. II. Discovery of Benzoxathiins as Potent, Selective Estrogen Receptor α Modulators
2004
·
Seongkon Kim
, Jane Y. Wu
, et al.
·
Journal of Medicinal Chemistry
·
108
Estrogen receptor-β regulates tryptophan hydroxylase-1 expression in the murine midbrain raphe
2005
·
Chrisana Gundlah
, Stephen E. Alves
, et al.
·
Biological Psychiatry
·
102
Estrogen receptor ligands. Part 16: 2-Aryl indoles as highly subtype selective ligands for ERα
2007
·
Kevin D. Dykstra
, Liangqin Guo
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
80
Estrogen receptor ligands. Part 9: Dihydrobenzoxathiin SERAMs with alkyl substituted pyrrolidine side chains and linkers
2004
·
Timothy A. Blizzard
, Frank DiNinno
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
67
Differential hormonal regulation of tryptophan hydroxylase-2 mRNA in the murine dorsal raphe nucleus
2005
·
Janet A. Clark
, Lee-Yuh Pai
, et al.
·
Biological Psychiatry
·
61
Estrogen receptor ligands. Part 10: Chromanes: old scaffolds for new SERAMs
2005
·
Qiang Tan
, Timothy A. Blizzard
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
52
Selective estrogen receptor-beta (SERM-beta) compounds modulate raphe nuclei tryptophan hydroxylase-1 (TPH-1) mRNA expression and cause antidepressant-like effects in the forced swim test
2012
·
J.A. Clark
, S. Alves
, et al.
·
Neuropharmacology
·
47
Discovery of a Highly Potent, Selective, and Bioavailable Soluble Epoxide Hydrolase Inhibitor with Excellent Ex Vivo Target Engagement
2009
·
Hong C. Shen
, Fa-Xiang Ding
, et al.
·
Journal of Medicinal Chemistry
·
47
Discovery of spirocyclic secondary amine-derived tertiary ureas as highly potent, selective and bioavailable soluble epoxide hydrolase inhibitors
2009
·
Hong C. Shen
, Fa-Xiang Ding
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
44
Estrogen receptor ligands. Part 11: Synthesis and activity of isochromans and isothiochromans
2004
·
Jian Liu
, Elizabeth T. Birzin
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
42
Pharmacologic Inhibition of the Renal Outer Medullary Potassium Channel Causes Diuresis and Natriuresis in the Absence of Kaliuresis
2013
·
Maria L. Garcia
, Birgit T. Priest
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
41
Discovery of MK-7145, an Oral Small Molecule ROMK Inhibitor for the Treatment of Hypertension and Heart Failure
2016
·
Haifeng Tang
, Yuping Zhu
, et al.
·
ACS Medicinal Chemistry Letters
·
40
A strategy of employing aminoheterocycles as amide mimics to identify novel, potent and bioavailable soluble epoxide hydrolase inhibitors
2009
·
Hong C. Shen
, Fa-Xiang Ding
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
34
Discovery of a novel sub-class of ROMK channel inhibitors typified by 5-(2-(4-(2-(4-(1H-Tetrazol-1-yl)phenyl)acetyl)piperazin-1-yl)ethyl)isobenzofuran-1(3H)-one
2013
·
Haifeng Tang
, Reynald K. de Jesus
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
33
Estrogen receptor ligands. Part 13: Dihydrobenzoxathiin SERAMs with an optimized antagonist side chain
2005
·
Timothy A. Blizzard
, Frank DiNinno
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
33
Estrogen receptor ligands. Part 7: Dihydrobenzoxathiin SERAMs with bicyclic amine side chains
2004
·
Timothy A Blizzard
, Frank DiNinno
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
33
Discovery of Benzimidazole CYP11B2 Inhibitors with in Vivo Activity in Rhesus Monkeys
2015
·
Scott B. Hoyt
, Min K. Park
, et al.
·
ACS Medicinal Chemistry Letters
·
27
Discovery of 3,3-disubstituted piperidine-derived trisubstituted ureas as highly potent soluble epoxide hydrolase inhibitors
2009
·
Hong C. Shen
, Fa-Xiang Ding
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
26
Estrogen receptor ligands. Part 8: Dihydrobenzoxathiin SERAMs with heteroatom-substituted side chains
2004
·
Timothy A Blizzard
, Frank DiNinno
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
22
Discovery of Triazole CYP11B2 Inhibitors with in Vivo Activity in Rhesus Monkeys
2015
·
Scott B. Hoyt
, Whitney Petrilli
, et al.
·
ACS Medicinal Chemistry Letters
·
20
Discovery of a Potent and Selective ROMK Inhibitor with Pharmacokinetic Properties Suitable for Preclinical Evaluation
2015
·
Shawn P. Walsh
, Aurash Shahripour
, et al.
·
ACS Medicinal Chemistry Letters
·
20
Estrogen receptor ligands. Part 14: Application of novel antagonist side chains to existing platforms
2005
·
Timothy A. Blizzard
, Jerry D. Morgan
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
19
Estrogen receptor ligands. Part 5: The SAR of dihydrobenzoxathiins containing modified basic side chains
2004
·
Qiang Tan
, Elizabeth T Birzin
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
19
The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
2016
·
Caryn Hampton
, Xiaoyan Zhou
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
17
Evaluation of selective inhibitors of 11β-HSD1 for the treatment of hypertension
2013
·
David R. Bauman
, Alan Whitehead
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
17
Show more works
View as search
Works count:
36
Citation count:
1,139
H-index:
20
I10-index:
31
Year
Topic
Type